Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare

Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy

NCT04069325 ·Status: UNKNOWN ·Phase: NA

Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout

NCT01336686 ·Status: COMPLETED ·Phase: PHASE2

A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout

NCT04052932 ·Status: COMPLETED ·Phase: PHASE3

Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study

NCT01029652 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout

NCT00663169 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Oral Febuxostat in Subjects With Gout

NCT02082769 ·Status: COMPLETED ·Phase: PHASE3

Study of FYU-981 in Hyperuricemia With or Without Gout

NCT02344862 ·Status: COMPLETED ·Phase: PHASE2

A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.

NCT06270225 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout

NCT05925166 ·Status: COMPLETED ·Phase: NA

Study of FYU-981 in Hyperuricemia With or Without Gout

NCT03006445 ·Status: COMPLETED ·Phase: PHASE3

A Phase Ib/II Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout

NCT05588908 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout

NCT06169891 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With Gout

NCT04956432 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)

NCT00819585 ·Status: COMPLETED ·Phase: PHASE2

Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients

NCT01431638 ·Status: COMPLETED ·Phase: PHASE3

Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout

NCT03635957 ·Status: COMPLETED ·Phase: PHASE4

Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients

NCT05119686 ·Status: COMPLETED ·Phase: PHASE2

Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients

NCT01399008 ·Status: COMPLETED ·Phase: PHASE2

Study of FYU-981 in Hyperuricemia With or Without Gout

NCT02416167 ·Status: COMPLETED ·Phase: PHASE2

Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

NCT05586958 ·Status: COMPLETED ·Phase: PHASE3

Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout

NCT04697602 ·Status: TERMINATED ·Phase: NA

A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients

NCT05815901 ·Status: COMPLETED ·Phase: PHASE3

The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout

NCT03131583 ·Status: COMPLETED ·Phase: PHASE1

Multiple Dose Study of SHR4640 in Healthy Subjects

NCT02890966 ·Status: COMPLETED ·Phase: PHASE1

Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate Levels

NCT02060552 ·Status: COMPLETED ·Phase: PHASE4